Раскильдина, Г.З.,
Валиев, В.Ф.,
Озден, И.В.,
Мещерякова, С.А.,
Спирихин, Л.В.,
Злоцкий, С.С.,
Raskildinaa, G.Z.,
Valieva, V.F.,
Ozdena, I.V.,
Meshcheryakova, S.A.,
Spirikhinc, L.V.,
Zlotskii, S.S. (2017) SYNTHESIS OF PYRINIDINE-
2,4(1H,3H)-DIONE DERIVATIVES CONTAINING N-ALKYL SUBSTITUENTS
Zagidullin, N.S.,
Dunayeva, A.R.,
Plechev, V.V.,
Gilmanov, A.Z.,
Zagidullin, S.Z.,
Er, F.,
Pavlov, V.N. (2017) . The patients were randomized for RIPC (n = 26, 60.5 ±
2.0 years) or
12
sRIPC (n = 25, 62.96 ± 1.7). RIPC
Thymidylate synthase (Th
S) is a target for antimetabolite antitumor drugs. Such drugs have been
Khusnutdinova, E.K.,
Dzhemileva, L.U.,
Lobov, S.L.,
Kuznetzov, D.U.,
Nazirova, A.G.,
Nurgalina, E.M.,
Barashkov, N.A.,
Fedorova, S.A. (2017) carrier frequency of c.35delG,
c.167delT and c.235delC mutations of the GJB
2 gene in 17 populations
Klen, E.E,
Nikitina, I.L.,
Makarova, N.N,
Miftakhova, A.F,
Ivanova, O.A,
Khaliullin, F.A.,
Alekhin, E.K. (2017) -(1,1-dioxothietan-3-yl)-1,
2,4-triazole with sodium phenolates and thiophenolate. The 5-aryloxy- and 5-arenesulfonyl